6505--Verapamil Hydrochloride (HCL) Tablets
ID: 36E79725R0006Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/9f6394888eec4648877b011679675e78/view
Timeline
    Description

    The Department of Veterans Affairs (VA) National Acquisition Center is issuing a presolicitation notice for Request for Proposal (RFP) #36E79725R0006 to procure Verapamil Hydrochloride (HCL) Tablets. This procurement aims to ensure an uninterrupted supply of the drug for various federal entities, including the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will have a duration of one year, with the potential for four additional one-year options, and the estimated annual requirements include specific dosages and quantities of the tablets. Interested vendors must submit their proposals by December 4, 2024, and are encouraged to check SAM.gov for updates regarding the solicitation. For inquiries, vendors can contact Contract Specialist Deborah Fassl at Deborah.Fassl@va.gov or by phone at 708-786-5894.

    Point(s) of Contact
    Deborah FasslContract Specialist
    (708) 786-5894
    Deborah.Fassl@va.gov
    Files
    Title
    Posted
    36E79725R0006_1.docx
    The Department of Veterans Affairs (VA) National Acquisition Center is issuing a presolicitation notice for a Request for Proposal (RFP) #36E79725R0006 to procure Verapamil Hydrochloride (HCL) Tablets. This procurement aims to provide an uninterrupted supply of the drug for various federal entities, including the VA, Department of Defense (DoD), and Bureau of Prisons. The contract will have a duration of one year, with the potential for four additional one-year options. The total estimated annual requirements for the tablets are specified, with different dosages and quantities listed. Interested vendors must submit their proposals by December 4, 2024, and need to check the SAM.gov website for any updates regarding the solicitation. The procurement emphasizes the need for a unique National Drug Code (NDC) number and the drug's name must match the label. The main contact for this procurement is Contract Specialist Deborah Fassl. This notice reflects the VA's commitment to maintaining consistent pharmaceutical supplies for veterans and other federal healthcare entities.
    Lifecycle
    Title
    Type
    6505--Verapamil Hydrochloride (HCL) Tablets
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Lamotrigine Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care facilities, including the Department of Defense and the Bureau of Prisons. The contract will cover an unrestricted procurement for multiple strengths and packaging sizes of Lamotrigine IR Tablets, with specific requirements for labeling and packaging to ensure compliance with safety standards. This procurement is critical for maintaining the availability of essential medications for veterans and other federal beneficiaries. Interested offerors should note that the solicitation is expected to be released on or about November 7, 2024, with a closing date of November 21, 2024; inquiries can be directed to Contract Specialist Ray Roldan at raymond.roldan@va.gov or by phone at 708-786-4930.
    6505--Omeprazole Dr Capsules- NAC Repack
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) National Acquisition Center is preparing to issue a Request for Proposal (RFP) 36E79725R0002 for the procurement of Omeprazole DR Capsules, aimed at supporting various health service agencies, including the VA, Bureau of Prisons, and others. This unrestricted procurement will award one contract per group, with a total contract duration of one year and the potential for four additional one-year option periods. The procurement is critical for ensuring a reliable supply of essential medications, with specific packaging requirements including safety caps and unique NDC numbers for the products. Interested offerors should note that the solicitation is expected to be released electronically on or around November 19, 2024, with a closing date of December 3, 2024. For further inquiries, interested parties can contact Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852.
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the supply of Norethindrone Acetate Tablets under Request for Proposal (RFP) 36E79724R0027. The procurement aims to establish contracts for the pharmaceutical product, with specific requirements regarding pricing for a base year and four option years, compliance with packaging standards, and adherence to the Drug Supply Chain Security Act (DSCSA) regulations. This medication is essential for various health treatments within the VA system, ensuring that veterans receive necessary pharmaceutical care. Interested contractors must submit their proposals by November 15, 2024, at 2:30 PM Central Standard Time, to the designated email addresses provided in the solicitation documents. For further inquiries, potential bidders can contact Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used for treating high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties can contact Catherine Gilbert for more information. The solicitation is projected to be issued in December 2019.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used to treat high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The solicitation will be posted on the DLA Bid Board System and beta.SAM.gov, with a projected solicitation date in June 2021. Interested parties should contact Christopher Newman for more information.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Betamethasone RFP
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Betamethasone Dipropionate Cream, a pharmaceutical product essential for the healthcare of veterans. Offerors are required to submit competitive pricing for a base year and four option years, including a mandatory 0.5% Cost Recovery Fee, while ensuring compliance with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is vital for maintaining a consistent supply of medications through the VA and Department of Defense's Prime Vendor Programs, emphasizing the government's commitment to providing quality healthcare to service members. Interested vendors should contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further details regarding the solicitation.
    6505-- Pegfilgrastim
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0001 for the procurement of Pegfilgrastim, aimed at ensuring a continuous supply for various entities including VA facilities, Consolidated Mail Order Pharmacies, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a responsible offeror capable of providing Pegfilgrastim with a unique National Drug Code (NDC) and adhering to strict labeling guidelines, prohibiting the affixing of new labels over existing ones. The estimated annual requirement is for 8,458 syringes across multiple variants, with the RFP expected to be released electronically around November 5, 2024, and responses due by November 19, 2024. Interested parties should monitor sam.gov for updates and direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6505--770-25-1-801-0021 -National CMOP DORZOLAMIDE/TIMOLOL -VA-25-00011267)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure DORZOLAMIDE/TIMOLOL ophthalmic solution for its Centralized Mail Order Pharmacy (CMOP) facilities. This procurement involves acquiring quantities ranging from 2,880 to 9,600 units of 10ML packaging, with a focus on ensuring compliance with the Drug Supply Chain Security Act and other regulatory standards. The pharmaceutical products are critical for providing necessary medical care to veterans, reflecting the VA's commitment to delivering high-quality healthcare solutions. Interested vendors must submit their quotations by November 12, 2024, following the release of the solicitation on November 4, 2024, and can direct inquiries to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Calcitonin Gene-Related Peptides (CGRP) through its Pharmaceutical Prime Vendor (PPV) Program. This procurement aims to establish a contract that ensures a consistent supply of these pharmaceutical products while adhering to federal regulations, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). The CGRP products are critical for various medical treatments within VA facilities, emphasizing the importance of quality control and reliable delivery. Interested offerors must submit their proposals by November 7, 2024, at 2:30 PM CT, and can direct inquiries to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov.